Janssen Biotech, Inc. | Patient Daily

Janssen Biotech, Inc.

Nicholas Gueguen | Aug 17, 2017

FDA gives Imbruvica go-ahead to aid patients with chronic graft versus host disease

Jamie Barrand | Mar 9, 2016

FDA approves Imbruvica as first-line therapy for chronic lymphocytic leukemia

Jamie Barrand | Sep 17, 2015

Janssen's multiple myeloma drug accepted for FDA priority review

Trending

C.D. Marsden | Apr 12, 2025

Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’

Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'

+ Pharmaceuticals

Patient Daily | Apr 15, 2025

UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'

+ Pharmaceuticals

Patient Daily | Apr 17, 2025

AI tool decodes cerebellar signals to improve understanding of brain disorders